NPS PHARMACEUTICALS INC | 11,90 Euro | +0,675 +6,01 % | |
| WKN: 900609 ISIN: US62936P1030 Ticker-Symbol: NPM | Frankfurt | 24.05.13 | 15:16 Uhr |
Branche PharmaAktienmarkt NASDAQ Biotech |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 24.05. | Possible Bearish Inside Day Candle Pattern Detected for NPS Pharmaceuticals | - | SmarTrend | |
| 24.05. | NPS Pharma Prices Offering | 1 | Zacks | |
| 22.05. | NPS PHARMACEUTICALS INC - 8-K, Current Report | - | SEC Filings | |
| 22.05. | NPS Pharmaceuticals Rising on Above-Average Volume, Consistent With Trend | - | SmarTrend | |
| 22.05. | NPS Pharmaceuticals Shares Climbing Higher, Up 6.0% | 1 | SmarTrend | |
| 22.05. | NPS Pharmaceuticals (NPSP) Prices 6M Common Stock Offering | 2 | StreetInsider.com | |
| 22.05. | Market seems ready for another injection of NPS Pharma | 2 | bizjournals | |
| 21.05. | NPS Pharmaceuticals Bullish Moving Average Crossover Alert | 1 | SmarTrend | |
| 14.05. | NPS Pharma Incurs Narrower 1Q Loss | 2 | Zacks | |
| 09.05. | Why NPS Pharmaceuticals Is Up After Earnings | 6 | Motley Fool | |
| 09.05. | NPS Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript | - | Seeking Alpha | |
| 09.05. | Needham hebt das Kursziel für NPS Pharma von $15 auf $20. | 143 | BörseGo | |
| Needham hebt das Kursziel für NPS Pharma von $15 auf $20.
(© BörseGo AG 2013 - Autor: Simon Hauser, Redakteur) Mehr lesen zu: Needham hebt das Kursziel für NPS Pharma von $15 auf $20. | ||||
| 09.05. | NPS Pharmaceuticals Crosses Above its 10-day MA | - | SmarTrend | |
| 09.05. | NPS PHARMACEUTICALS INC - 10-Q, Quaterly Report | 1 | SEC Filings | |
| 09.05. | NPS PHARMACEUTICALS INC - 8-K, Current Report | - | SEC Filings | |
| 02.05. | Possible Bullish Inside Day Candle Pattern Detected for NPS Pharmaceuticals | - | SmarTrend | |
| 29.04. | Shares of NPS Pharmaceuticals Rise to a New 52-Week High | 1 | SmarTrend | |
| 22.04. | Shares of NPS Pharmaceuticals Has Risen Above Previous 52-Week High | 2 | SmarTrend | |
| 19.04. | Stock Investors Bid Up Shares of NPS Pharmaceuticals, Up 6.4% | 4 | SmarTrend | |
| 19.04. | Bullish Moving Average Cross by NPS Pharmaceuticals | 3 | SmarTrend | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| CELGENE | 94,61 | -1,50 % | Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE sNDA in Advanced Pancreatic Cancer |
| ASTEX PHARMACEUTICALS | 4,082 | +2,77 % | Astex Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-20-2013 03:30 PM |
| BIOMARIN PHARMACEUTICAL | 50,94 | +2,29 % | BioMarin Gains on Prospects for Experimental Cancer Drug |
| PFIZER | 22,452 | -0,10 % | Pfizer spaltet Tierarzneisparte Zoetis endgültig ab |
| STADA ARZNEIMITTEL | 34,05 | +0,43 % | Stada: Deutsche Bank zeigt Interesse |
